• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与膀胱癌风险:一项基于台湾全民健康保险数据库的研究。

Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.

机构信息

Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei (100), Taiwan, Republic of China.

出版信息

Diabetologia. 2011 Aug;54(8):2009-15. doi: 10.1007/s00125-011-2171-z. Epub 2011 May 5.

DOI:10.1007/s00125-011-2171-z
PMID:21544514
Abstract

AIMS/HYPOTHESIS: Studies on the link between diabetes and bladder cancer in Asians are rare. We investigated the association between diabetes and incidence of bladder cancer by using a large national insurance database.

METHODS

A random sample of 1,000,000 individuals covered by the National Health Insurance was recruited. A total of 495,199 men and 503,748 women for all ages and 187,609 men and 189,762 women ≥40 years old and without bladder cancer at recruitment were followed from 2003 to 2005. Cox regression evaluated the adjusted relative risk for all ages and for age ≥40 years old.

RESULTS

The results were similar for all ages and for age ≥40 years. In Cox models, patients with diabetes consistently showed a significantly higher relative risk ranging from 1.36 to 1.51 after adjustment for age, sex and other potential confounders. Age, male sex, nephropathy, urinary tract diseases (infection and stone) and statin use were associated with bladder cancer, but occupation, hypertension, stroke, ischaemic heart disease, peripheral arterial disease, eye disease, dyslipidaemia and medications (oral glucose-lowering agents including sulfonylurea, metformin, acarbose and thiazolidinediones, insulin, fibrates, ACE inhibitors/angiotensin receptor blockers and calcium channel blockers) were not. Chronic obstructive pulmonary disease and living in regions other than Metropolitan Taipei were associated with lower risk.

CONCLUSIONS

Patients with diabetes have a higher risk of bladder cancer. The association with urinary tract diseases suggests a complex scenario in the link between bladder cancer and diabetes at different disease stages.

摘要

目的/假设:亚洲关于糖尿病与膀胱癌之间关联的研究较少。我们利用一个大型医疗保险数据库研究了糖尿病与膀胱癌发病率之间的关联。

方法

招募了一个由 100 万医疗保险覆盖的随机抽样个体。对所有年龄段的 495199 名男性和 503748 名女性,以及≥40 岁且入组时无膀胱癌的 187609 名男性和 189762 名女性进行随访,随访时间从 2003 年至 2005 年。Cox 回归评估了所有年龄段和≥40 岁的年龄调整相对风险。

结果

所有年龄段和≥40 岁的结果相似。在 Cox 模型中,患有糖尿病的患者在调整年龄、性别和其他潜在混杂因素后,始终表现出显著更高的相对风险,范围从 1.36 到 1.51。年龄、男性、肾病、下尿路疾病(感染和结石)和他汀类药物的使用与膀胱癌相关,但职业、高血压、中风、缺血性心脏病、外周动脉疾病、眼病、血脂异常和药物(包括磺脲类、二甲双胍、阿卡波糖和噻唑烷二酮、胰岛素、贝特类药物、ACE 抑制剂/血管紧张素受体阻滞剂和钙通道阻滞剂的口服降糖药)与膀胱癌无关。慢性阻塞性肺疾病和居住在大台北地区以外的地区与较低的风险相关。

结论

糖尿病患者患膀胱癌的风险更高。与下尿路疾病的关联表明,在不同疾病阶段,膀胱癌与糖尿病之间的关联存在复杂情况。

相似文献

1
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.糖尿病与膀胱癌风险:一项基于台湾全民健康保险数据库的研究。
Diabetologia. 2011 Aug;54(8):2009-15. doi: 10.1007/s00125-011-2171-z. Epub 2011 May 5.
2
Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.良性前列腺增生是糖尿病患者膀胱癌的重要危险因素:一项基于人群的使用台湾全民健康保险的队列研究。
BMC Cancer. 2013 Jan 4;13:7. doi: 10.1186/1471-2407-13-7.
3
Oral cancer in Taiwan: is diabetes a risk factor?台湾口腔癌:糖尿病是危险因素吗?
Clin Oral Investig. 2013 Jun;17(5):1357-64. doi: 10.1007/s00784-012-0820-3. Epub 2012 Aug 16.
4
Diabetes and risk of prostate cancer: a study using the National Health Insurance.糖尿病与前列腺癌风险:基于国民健康保险的研究。
Diabetes Care. 2011 Mar;34(3):616-21. doi: 10.2337/dc10-1640. Epub 2011 Jan 27.
5
Thyroid cancer risk is not increased in diabetic patients.糖尿病患者的甲状腺癌风险并未增加。
PLoS One. 2012;7(12):e53096. doi: 10.1371/journal.pone.0053096. Epub 2012 Dec 27.
6
Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.台湾糖尿病患者队列研究中按年龄、性别和地理区域分层的肾和膀胱恶性肿瘤风险
Medicine (Baltimore). 2015 Sep;94(38):e1494. doi: 10.1097/MD.0000000000001494.
7
Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study.糖尿病、胰岛素使用与幽门螺杆菌根除:一项回顾性队列研究。
BMC Gastroenterol. 2012 May 9;12:46. doi: 10.1186/1471-230X-12-46.
8
Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.2型糖尿病与肾癌风险:一项基于国民健康保险的回顾性队列分析
PLoS One. 2015 Nov 11;10(11):e0142480. doi: 10.1371/journal.pone.0142480. eCollection 2015.
9
Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.糖尿病患者胃肠道恶性肿瘤风险增加及其与抗糖尿病药物的相关性:台湾一项基于全国人口的研究
Intern Med. 2013;52(9):939-46. doi: 10.2169/internalmedicine.52.8276. Epub 2012 Mar 1.
10
Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study.2 型糖尿病患者膀胱癌的发病率:一项基于人群的队列研究。
Medicina (Kaunas). 2020 Aug 31;56(9):441. doi: 10.3390/medicina56090441.

引用本文的文献

1
A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer.一项关于空腹血糖升高对七种癌症风险影响的举证责任研究。
Sci Rep. 2025 Aug 7;15(1):28859. doi: 10.1038/s41598-025-13045-9.
2
PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients.过氧化物酶体增殖物激活受体γ激动剂吡格列酮与2型糖尿病患者的恶性肿瘤风险
Acta Diabetol. 2025 Apr;62(4):531-542. doi: 10.1007/s00592-024-02378-y. Epub 2024 Sep 30.
3
Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system.

本文引用的文献

1
Diabetes and risk of bladder cancer: evidence from a case-control study in New England.糖尿病与膀胱癌风险:来自新英格兰地区病例对照研究的证据。
Cancer. 2011 Apr 1;117(7):1552-6. doi: 10.1002/cncr.25641. Epub 2010 Nov 8.
2
Bladder Cancer Working Group report.膀胱癌工作组报告。
Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i57-64. doi: 10.1093/jjco/hyq128.
3
Mortality in COPD: causes, risk factors, and prevention.慢性阻塞性肺疾病的死亡率:病因、危险因素和预防。
钠-葡萄糖共转运蛋白 2 抑制剂与美国食品药品监督管理局不良事件报告系统中的肾癌。
Eur J Clin Pharmacol. 2024 Dec;80(12):1959-1966. doi: 10.1007/s00228-024-03759-6. Epub 2024 Sep 17.
4
The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis.二甲双胍对膀胱癌发病率和预后的影响:一项系统评价和荟萃分析。
Bladder Cancer. 2022 Jun 3;8(2):211-228. doi: 10.3233/BLC-211653. eCollection 2022.
5
The Effect of Statins on the Incidence and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.他汀类药物对膀胱癌发病率和预后的影响:系统评价和荟萃分析。
Curr Oncol. 2023 Jul 12;30(7):6648-6665. doi: 10.3390/curroncol30070488.
6
Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019.高空腹血糖导致膀胱癌负担的估计:2019 年全球疾病负担研究的结果。
Cancer Med. 2023 Aug;12(15):16469-16481. doi: 10.1002/cam4.6219. Epub 2023 Jun 23.
7
SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.SGLT-2抑制剂在癌症治疗中的作用机制及新出现的观点
Cancers (Basel). 2022 Nov 25;14(23):5811. doi: 10.3390/cancers14235811.
8
The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies.代谢综合征及其组分与膀胱癌的关系:队列研究的系统评价和荟萃分析。
Epidemiol Health. 2022;44:e2022050. doi: 10.4178/epih.e2022050. Epub 2022 May 30.
9
Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.吡格列酮与 2 型糖尿病患者慢性阻塞性肺疾病风险:一项回顾性队列研究。
Int J Chron Obstruct Pulmon Dis. 2022 Feb 9;17:285-295. doi: 10.2147/COPD.S345796. eCollection 2022.
10
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study.非酒精性脂肪性肝病和胰岛素抵抗与非转移性膀胱癌患者的关联:一项横断面回顾性研究。
J Clin Med. 2021 Jan 18;10(2):346. doi: 10.3390/jcm10020346.
COPD. 2010 Oct;7(5):375-82. doi: 10.3109/15412555.2010.510160.
4
Female bladder cancer: incidence, treatment, and outcome.女性膀胱癌:发病率、治疗和预后。
Curr Opin Urol. 2010 Sep;20(5):404-8. doi: 10.1097/MOU.0b013e32833c7a9b.
5
Bladder cancer in 2010: how far have we come?2010 年膀胱癌:我们已经走了多远?
CA Cancer J Clin. 2010 Jul-Aug;60(4):244-72. doi: 10.3322/caac.20077. Epub 2010 Jun 21.
6
Environmental factors and genetic susceptibility promote urinary bladder cancer.环境因素和遗传易感性促进膀胱癌的发生。
Toxicol Lett. 2010 Mar 15;193(2):131-7. doi: 10.1016/j.toxlet.2009.12.018. Epub 2010 Jan 4.
7
Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive.吡格列酮在2型糖尿病高危患者中的安全性和耐受性:PROactive研究数据概述
Drug Saf. 2009;32(3):187-202. doi: 10.2165/00002018-200932030-00002.
8
Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan.糖尿病患者膀胱癌的年龄相关死亡风险:台湾全国队列的12年随访
Ann Med. 2009;41(5):371-9. doi: 10.1080/07853890902729778.
9
Urinary tract infections and reduced risk of bladder cancer in Los Angeles.洛杉矶的尿路感染与膀胱癌风险降低
Br J Cancer. 2009 Mar 10;100(5):834-9. doi: 10.1038/sj.bjc.6604889. Epub 2009 Jan 27.
10
Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men.瑞典男性前瞻性研究中的糖尿病、体型与膀胱癌风险
Eur J Cancer. 2008 Nov;44(17):2655-60. doi: 10.1016/j.ejca.2008.07.012. Epub 2008 Aug 15.